Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Neuroimaging Advances for Depression.

Dunlop BW, Mayberg HS.

Cerebrum. 2017 Nov 1;2017. pii: cer-16-17. eCollection 2017 Nov-Dec.

2.

Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder.

Dunlop BW, Polychroniou PE, Rakofsky JJ, Nemeroff CB, Craighead WE, Mayberg HS.

Psychol Med. 2018 Sep 12:1-10. doi: 10.1017/S0033291718002568. [Epub ahead of print]

PMID:
30207254
3.

Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response.

Syed SA, Beurel E, Loewenstein DA, Lowell JA, Craighead WE, Dunlop BW, Mayberg HS, Dhabhar F, Dietrich WD, Keane RW, de Rivero Vaccari JP, Nemeroff CB.

Neuron. 2018 Sep 5;99(5):914-924.e3. doi: 10.1016/j.neuron.2018.08.001. Epub 2018 Aug 23.

PMID:
30146307
4.

Test-retest reliability of a stimulation-locked evoked response to deep brain stimulation in subcallosal cingulate for treatment resistant depression.

Waters AC, Veerakumar A, Choi KS, Howell B, Tiruvadi V, Bijanki KR, Crowell A, Riva-Posse P, Mayberg HS.

Hum Brain Mapp. 2018 Aug 18. doi: 10.1002/hbm.24327. [Epub ahead of print]

PMID:
30120851
5.

Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults.

Polychroniou PE, Mayberg HS, Craighead WE, Rakofsky JJ, Aponte Rivera V, Haroon E, Dunlop BW.

Behav Sci (Basel). 2018 Jul 17;8(7). pii: E64. doi: 10.3390/bs8070064.

6.

Initial Unilateral Exposure to Deep Brain Stimulation in Treatment-Resistant Depression Patients Alters Spectral Power in the Subcallosal Cingulate.

Smart O, Choi KS, Riva-Posse P, Tiruvadi V, Rajendra J, Waters AC, Crowell AL, Edwards J, Gross RE, Mayberg HS.

Front Comput Neurosci. 2018 Jun 12;12:43. doi: 10.3389/fncom.2018.00043. eCollection 2018.

7.

Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders.

Ahmed AT, Frye MA, Rush AJ, Biernacka JM, Craighead WE, McDonald WM, Bobo WV, Riva-Posse P, Tye SJ, Mayberg HS, Hall-Flavin DK, Skime MK, Jenkins GD, Wang L, Krishnan RR, Weinshilboum RM, Kaddurah-Daouk R, Dunlop BW; Mood Disorders Precision Medicine Consortium (MDPMC).

J Affect Disord. 2018 Oct 1;238:1-7. doi: 10.1016/j.jad.2018.05.005. Epub 2018 May 26.

PMID:
29807322
8.

Can a Framework Be Established for the Safe Use of Ketamine?

Freedman R, Brown AS, Cannon TD, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, Rush AJ, Tamminga CA, Tohen M, Vieta E, Wisner KL, Xin Y.

Am J Psychiatry. 2018 Jul 1;175(7):587-589. doi: 10.1176/appi.ajp.2018.18030290. Epub 2018 Apr 16. No abstract available.

PMID:
29656666
9.

Functional movement disorders arising after successful deep brain stimulation.

Breen DP, Rohani M, Moro E, Mayberg HS, Zurowski M, Lozano AM, Fasano A.

Neurology. 2018 May 15;90(20):931-932. doi: 10.1212/WNL.0000000000005530. Epub 2018 Apr 13. No abstract available.

PMID:
29653985
10.

Placebo Effects Across Self-Report, Clinician Rating, and Objective Performance Tasks Among Women With Post-Traumatic Stress Disorder: Investigation of Placebo Response in a Pharmacological Treatment Study of Post-Traumatic Stress Disorder.

Hodgins GE, Blommel JG, Dunlop BW, Iosifescu D, Mathew SJ, Neylan TC, Mayberg HS, Harvey PD.

J Clin Psychopharmacol. 2018 Jun;38(3):200-206. doi: 10.1097/JCP.0000000000000858.

PMID:
29505471
11.

Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank.

Ramirez-Zamora A, Giordano JJ, Gunduz A, Brown P, Sanchez JC, Foote KD, Almeida L, Starr PA, Bronte-Stewart HM, Hu W, McIntyre C, Goodman W, Kumsa D, Grill WM, Walker HC, Johnson MD, Vitek JL, Greene D, Rizzuto DS, Song D, Berger TW, Hampson RE, Deadwyler SA, Hochberg LR, Schiff ND, Stypulkowski P, Worrell G, Tiruvadi V, Mayberg HS, Jimenez-Shahed J, Nanda P, Sheth SA, Gross RE, Lempka SF, Li L, Deeb W, Okun MS.

Front Neurosci. 2018 Jan 24;11:734. doi: 10.3389/fnins.2017.00734. eCollection 2017.

12.

A Shared Vision for Machine Learning in Neuroscience.

Vu MT, Adalı T, Ba D, Buzsáki G, Carlson D, Heller K, Liston C, Rudin C, Sohal VS, Widge AS, Mayberg HS, Sapiro G, Dzirasa K.

J Neurosci. 2018 Feb 14;38(7):1601-1607. doi: 10.1523/JNEUROSCI.0508-17.2018. Epub 2018 Jan 26.

13.

Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders.

Bari AA, Mikell CB, Abosch A, Ben-Haim S, Buchanan RJ, Burton AW, Carcieri S, Cosgrove GR, D'Haese PF, Daskalakis ZJ, Eskandar EN, Gerrard JL, Goodman WK, Greenberg BD, Gross RE, Hamani C, Kiss ZHT, Konrad P, Kopell BH, Krinke L, Langevin JP, Lozano AM, Malone D, Mayberg HS, Miller JP, Patil PG, Peichel D, Petersen EA, Rezai AR, Richardson RM, Riva-Posse P, Sankar T, Schwalb JM, Simpson HB, Slavin K, Stypulkowski PH, Tosteson T, Warnke P, Willie JT, Zaghloul KA, Neimat JS, Pouratian N, Sheth SA.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):886-896. doi: 10.1136/jnnp-2017-317082. Epub 2018 Jan 25.

PMID:
29371415
14.

Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence.

Kennedy JC, Dunlop BW, Craighead LW, Nemeroff CB, Mayberg HS, Craighead WE.

J Consult Clin Psychol. 2018 Feb;86(2):189-199. doi: 10.1037/ccp0000279.

PMID:
29369664
15.

Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.

Dunlop BW, Cole SP, Nemeroff CB, Mayberg HS, Craighead WE.

J Affect Disord. 2018 Mar 15;229:111-119. doi: 10.1016/j.jad.2017.12.035. Epub 2017 Dec 27.

PMID:
29306690
16.

Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.

Carrillo-Roa T, Labermaier C, Weber P, Herzog DP, Lareau C, Santarelli S, Wagner KV, Rex-Haffner M, Harbich D, Scharf SH, Nemeroff CB, Dunlop BW, Craighead WE, Mayberg HS, Schmidt MV, Uhr M, Holsboer F, Sillaber I, Binder EB, Müller MB.

PLoS Biol. 2017 Dec 28;15(12):e2002690. doi: 10.1371/journal.pbio.2002690. eCollection 2017 Dec.

17.

Impact of brain shift on subcallosal cingulate deep brain stimulation.

Choi KS, Noecker AM, Riva-Posse P, Rajendra JK, Gross RE, Mayberg HS, McIntyre CC.

Brain Stimul. 2018 Mar - Apr;11(2):445-453. doi: 10.1016/j.brs.2017.12.001. Epub 2017 Dec 6.

PMID:
29246748
18.

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM.

Am J Psychiatry. 2018 Mar 1;175(3):251-261. doi: 10.1176/appi.ajp.2017.17020172. Epub 2017 Dec 15.

PMID:
29241359
19.

Brain-Based Biomarkers for the Treatment of Depression: Evolution of an Idea.

Waters AC, Mayberg HS.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):870-880. doi: 10.1017/S1355617717000881. Review.

PMID:
29198278
20.

Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.

Holtzheimer PE, Husain MM, Lisanby SH, Taylor SF, Whitworth LA, McClintock S, Slavin KV, Berman J, McKhann GM, Patil PG, Rittberg BR, Abosch A, Pandurangi AK, Holloway KL, Lam RW, Honey CR, Neimat JS, Henderson JM, DeBattista C, Rothschild AJ, Pilitsis JG, Espinoza RT, Petrides G, Mogilner AY, Matthews K, Peichel D, Gross RE, Hamani C, Lozano AM, Mayberg HS.

Lancet Psychiatry. 2017 Nov;4(11):839-849. doi: 10.1016/S2215-0366(17)30371-1. Epub 2017 Oct 4.

PMID:
28988904
21.

The Structure of Personality Disorders within a Depressed Sample: Implications for Personalizing Treatment.

Berg JM, Kennedy JC, Dunlop BW, Ramirez CL, Stewart LM, Nemeroff CB, Mayberg HS, Craighead WE.

Pers Med Psychiatry. 2017 Mar-Apr;1-2:59-64. doi: 10.1016/j.pmip.2016.12.005. Epub 2017 Jan 5.

22.

Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder.

Dunlop BW, Binder EB, Iosifescu D, Mathew SJ, Neylan TC, Pape JC, Carrillo-Roa T, Green C, Kinkead B, Grigoriadis D, Rothbaum BO, Nemeroff CB, Mayberg HS.

Biol Psychiatry. 2017 Dec 15;82(12):866-874. doi: 10.1016/j.biopsych.2017.06.024. Epub 2017 Jul 4.

PMID:
28793974
23.

StimVision Software: Examples and Applications in Subcallosal Cingulate Deep Brain Stimulation for Depression.

Noecker AM, Choi KS, Riva-Posse P, Gross RE, Mayberg HS, McIntyre CC.

Neuromodulation. 2018 Feb;21(2):191-196. doi: 10.1111/ner.12625. Epub 2017 Jun 27.

PMID:
28653482
24.

A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression.

Riva-Posse P, Choi KS, Holtzheimer PE, Crowell AL, Garlow SJ, Rajendra JK, McIntyre CC, Gross RE, Mayberg HS.

Mol Psychiatry. 2018 Apr;23(4):843-849. doi: 10.1038/mp.2017.59. Epub 2017 Apr 11.

25.

Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.

Dunlop BW, Kelley ME, Aponte-Rivera V, Mletzko-Crowe T, Kinkead B, Ritchie JC, Nemeroff CB, Craighead WE, Mayberg HS; PReDICT Team.

Am J Psychiatry. 2017 Jun 1;174(6):546-556. doi: 10.1176/appi.ajp.2016.16050517. Epub 2017 Mar 24.

PMID:
28335624
26.

Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS.

Am J Psychiatry. 2017 Jun 1;174(6):533-545. doi: 10.1176/appi.ajp.2016.16050518. Epub 2017 Mar 24. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

27.

Neurocognitive Predictors of Response in Treatment Resistant Depression to Subcallosal Cingulate Gyrus Deep Brain Stimulation.

McInerney SJ, McNeely HE, Geraci J, Giacobbe P, Rizvi SJ, Ceniti AK, Cyriac A, Mayberg HS, Lozano AM, Kennedy SH.

Front Hum Neurosci. 2017 Feb 24;11:74. doi: 10.3389/fnhum.2017.00074. eCollection 2017.

28.

Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

Nat Med. 2017 Feb 7;23(2):264. doi: 10.1038/nm0217-264d. No abstract available.

29.

Being open minded about neuromodulation trials: Finding success in our "failures".

Fins JJ, Kubu CS, Mayberg HS, Merkel R, Nuttin B, Schlaepfer TE.

Brain Stimul. 2017 Mar - Apr;10(2):181-186. doi: 10.1016/j.brs.2016.12.012. Epub 2016 Dec 23.

PMID:
28159536
30.

Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.

Deeb W, Giordano JJ, Rossi PJ, Mogilner AY, Gunduz A, Judy JW, Klassen BT, Butson CR, Van Horne C, Deny D, Dougherty DD, Rowell D, Gerhardt GA, Smith GS, Ponce FA, Walker HC, Bronte-Stewart HM, Mayberg HS, Chizeck HJ, Langevin JP, Volkmann J, Ostrem JL, Shute JB, Jimenez-Shahed J, Foote KD, Wagle Shukla A, Rossi MA, Oh M, Pourfar M, Rosenberg PB, Silburn PA, de Hemptine C, Starr PA, Denison T, Akbar U, Grill WM, Okun MS.

Front Integr Neurosci. 2016 Nov 22;10:38. eCollection 2016.

31.

Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

Nat Med. 2017 Jan;23(1):28-38. doi: 10.1038/nm.4246. Epub 2016 Dec 5. Erratum in: Nat Med. 2017 Feb 7;23 (2):264.

32.

A Symmetry-Based Method to Infer Structural Brain Networks from Probabilistic Tractography Data.

Shadi K, Bakhshi S, Gutman DA, Mayberg HS, Dovrolis C.

Front Neuroinform. 2016 Nov 4;10:46. eCollection 2016.

33.

Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.

Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.

Psychoneuroendocrinology. 2016 Jul;69:161-71. doi: 10.1016/j.psyneuen.2016.04.003. Epub 2016 Apr 14.

PMID:
27107207
34.

Deep Brain Stimulation for Depression: Keeping an Eye on a Moving Target.

Mayberg HS, Riva-Posse P, Crowell AL.

JAMA Psychiatry. 2016 May 1;73(5):439-40. doi: 10.1001/jamapsychiatry.2016.0173. No abstract available.

PMID:
27049731
35.

Implementing Recommendations for Depression Screening of Adults: How Can Neurology Contribute to the Dialogue?

Mayberg HS.

JAMA Neurol. 2016 Mar;73(3):270-1. doi: 10.1001/jamaneurol.2015.5048. No abstract available.

PMID:
26813997
36.

A Computational Model of Major Depression: the Role of Glutamate Dysfunction on Cingulo-Frontal Network Dynamics.

Ramirez-Mahaluf JP, Roxin A, Mayberg HS, Compte A.

Cereb Cortex. 2017 Jan 1;27(1):660-679. doi: 10.1093/cercor/bhv249.

37.

A Bayesian hierarchical framework for modeling brain connectivity for neuroimaging data.

Chen S, Bowman FD, Mayberg HS.

Biometrics. 2016 Jun;72(2):596-605. doi: 10.1111/biom.12433. Epub 2015 Oct 26.

38.
39.

Mapping the "Depression Switch" During Intraoperative Testing of Subcallosal Cingulate Deep Brain Stimulation.

Choi KS, Riva-Posse P, Gross RE, Mayberg HS.

JAMA Neurol. 2015 Nov;72(11):1252-60. doi: 10.1001/jamaneurol.2015.2564.

40.

Depressive symptoms related to low fractional anisotropy of white matter underlying the right ventral anterior cingulate in older adults with atherosclerotic vascular disease.

Bijanki KR, Matsui JT, Mayberg HS, Magnotta VA, Arndt S, Johnson HJ, Nopoulos P, Paradiso S, McCormick LM, Fiedorowicz JG, Epping EA, Moser DJ.

Front Hum Neurosci. 2015 Jul 15;9:408. doi: 10.3389/fnhum.2015.00408. eCollection 2015.

41.

Characterizing the therapeutic response to deep brain stimulation for treatment-resistant depression: a single center long-term perspective.

Crowell AL, Garlow SJ, Riva-Posse P, Mayberg HS.

Front Integr Neurosci. 2015 Jun 15;9:41. doi: 10.3389/fnint.2015.00041. eCollection 2015.

42.

Preliminary Findings Supporting Insula Metabolic Activity as a Predictor of Outcome to Psychotherapy and Medication Treatments for Depression.

Dunlop BW, Kelley ME, McGrath CL, Craighead WE, Mayberg HS.

J Neuropsychiatry Clin Neurosci. 2015 Summer;27(3):237-9. doi: 10.1176/appi.neuropsych.14030048. Epub 2015 Jun 12.

43.

Neuroimaging-based biomarkers for treatment selection in major depressive disorder.

Dunlop BW, Mayberg HS.

Dialogues Clin Neurosci. 2014 Dec;16(4):479-90. Review.

44.

Multimodal approaches to define network oscillations in depression.

Smart OL, Tiruvadi VR, Mayberg HS.

Biol Psychiatry. 2015 Jun 15;77(12):1061-70. doi: 10.1016/j.biopsych.2015.01.002. Epub 2015 Jan 28. Review.

45.

Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression.

Hilimire MR, Mayberg HS, Holtzheimer PE, Broadway JM, Parks NA, DeVylder JE, Corballis PM.

Brain Stimul. 2015 Mar-Apr;8(2):185-91. doi: 10.1016/j.brs.2014.11.010. Epub 2014 Nov 24.

46.

MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity.

Issler O, Haramati S, Paul ED, Maeno H, Navon I, Zwang R, Gil S, Mayberg HS, Dunlop BW, Menke A, Awatramani R, Binder EB, Deneris ES, Lowry CA, Chen A.

Neuron. 2014 Jul 16;83(2):344-360. doi: 10.1016/j.neuron.2014.05.042. Epub 2014 Jun 19.

47.

Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial.

Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, Kelley ME, Kinkead B, Kutner M, Iosifescu DV, Mathew SJ, Neylan TC, Kilts CD, Nemeroff CB, Mayberg HS.

Trials. 2014 Jun 21;15:240. doi: 10.1186/1745-6215-15-240.

48.

Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression.

Riva-Posse P, Choi KS, Holtzheimer PE, McIntyre CC, Gross RE, Chaturvedi A, Crowell AL, Garlow SJ, Rajendra JK, Mayberg HS.

Biol Psychiatry. 2014 Dec 15;76(12):963-9. doi: 10.1016/j.biopsych.2014.03.029. Epub 2014 Apr 13.

49.

Neuropsychological function before and after subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression.

Moreines JL, McClintock SM, Kelley ME, Holtzheimer PE, Mayberg HS.

Depress Anxiety. 2014 Aug;31(8):690-8. doi: 10.1002/da.22263. Epub 2014 Apr 17.

50.

Neuroimaging and psychiatry: the long road from bench to bedside.

Mayberg HS.

Hastings Cent Rep. 2014 Mar-Apr;Spec No:S31-6. doi: 10.1002/hast.296.

PMID:
24634083

Supplemental Content

Loading ...
Support Center